Neurofibroma — Trials

Neurofibroma — Trials · CancerIndex

Clinical trials

Registered studies

55 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01362803	AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors	active not recruiting	Phase 1 / Phase 2	99	National Cancer Institute (NCI)NIH	1	Sep 28, 2026	clinicaltrials
NCT03962543	MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas(ReNeu)	active not recruiting	Phase 2	114	SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, GermanyINDUSTRY